Peptide Therapy: A Plain-English Guide

Peptide therapy has become one of the most-discussed and most-misrepresented categories in wellness medicine. The biology is real, the clinical applications are real, and the gray-market versions of the same molecules — sourced from research-chemical sites with minimal oversight — are responsible for a steady stream of complications.

This piece is the version we'd want any new patient to read before their first consult.

What a peptide actually is

A peptide is a short chain of amino acids — usually under 50 residues — that serves as a biological signal. Hormones like insulin and growth hormone are technically peptides. So is oxytocin. So is glucagon. Your body manufactures and uses thousands of peptides every day to communicate between cells and tissues.

Therapeutic peptides are either replicas of those endogenous signals (e.g., growth hormone-releasing hormone analogs) or designed molecules that mimic them with longer half-lives or more selective activity (e.g., semaglutide as a GLP-1 analog).

Compared to a small-molecule drug, peptides tend to be more specific (less off-target activity) but also more fragile (require injection or specific delivery, sensitive to degradation).

What categories of peptides we use

The clinical landscape, simplified:

• Growth hormone secretagogues — Sermorelin, Ipamorelin, CJC-1295, Tesamorelin. Stimulate the pituitary to release growth hormone in a more physiologic, pulsatile pattern than direct GH replacement.
• Tissue repair — BPC-157, TB-500. Used adjunctively in injury recovery, joint health, and (in oral form) GI conditions.
• Metabolic and weight management — Semaglutide, Tirzepatide, Retatrutide, AOD-9604, 5-Amino-1MQ. Different mechanisms for different patients.
• Cellular and mitochondrial — NAD+, MOTS-c, SS-31. The cellular-energy and longevity end of the toolkit.
• Cognitive and neuroprotective — Selank, Semax. Russian-developed peptides with anxiolytic and cognitive-supportive effects.
• Sexual health and libido — PT-141, Kisspeptin. Targeted interventions for specific patients.
• Skin, hair, regeneration — GHK-Cu, Glow Stack. Collagen synthesis and tissue regeneration.
• Immunity — Thymosin Alpha-1, LL-37. Immune modulation and antimicrobial activity.
• Sleep — DSIP, Epithalon. Modulating sleep architecture and circadian regulation.

This is a directory, not a recommendation list. The right peptide for a patient — or the right answer of "none of these" — depends on goals, labs, and clinical context.

What to expect from a real protocol

A responsible peptide protocol includes:

1. A real clinical evaluation. History, goals, current labs. The protocol shouldn't precede the diagnosis.
2. Targeted bloodwork. Specific to the peptide and patient. Not "every lab under the sun"; not "no labs at all."
3. A written plan. The exact peptide, dose, route, frequency, and duration. What you're watching for, what would trigger a change, when you reassess.
4. A vetted pharmacy source. 503A or 503B compounding, with certificates of analysis and a real supply chain.
5. Clear instructions. Reconstitution if injectable, storage, what to do if you miss a dose, what to do if you have a side effect.
6. Follow-up. Typically 4–8 weeks after start, then on protocol-specific intervals. Lab repeat as needed.

If any of the above is missing, the protocol is, by definition, not a complete one. Some of the most common patient stories we hear — "I was on this for six months from a website and never had labs done" — are about exactly this gap.

What the gray market gets wrong

The risks of unmonitored peptide use, in order of frequency:

• Misdiagnosis. A patient self-diagnoses an issue that isn't actually what they think it is, and treats the wrong thing for months.
• Wrong dose, wrong duration. Often too high, sometimes for too long, sometimes both.
• Unregulated source quality. Concentration may be off; contaminants are a real possibility; sterility is a separate question entirely.
• Unmanaged side effects. No clinician means no one to call when something is off.
• Drug and condition interactions. Peptides interact with conditions and other medications. The patient who self-treats almost always has a blind spot they don't know is a blind spot.

What we tell new patients

Peptide therapy is real medicine. It works when prescribed, dosed, and monitored correctly. It's not magic. It's not a substitute for sleep, training, nutrition, or hormone optimization where indicated. The peptide is the last 10% of the protocol, not the first 80%. We treat it that way, and we expect patients to do the same.

If a peptide is the right tool for what you're trying to accomplish, we'll prescribe it. If it isn't, we'll tell you that, too.